Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity.

Falahat R, Perez-Villarroel P, Mailloux AW, Zhu G, Pilon-Thomas S, Barber GN, Mulé JJ.

Cancer Immunol Res. 2019 Nov;7(11):1837-1848. doi: 10.1158/2326-6066.CIR-19-0229. Epub 2019 Aug 28.

PMID:
31462408
2.

Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line.

Zhu G, Nemoto S, Mailloux AW, Perez-Villarroel P, Nakagawa R, Falahat R, Berglund AE, Mulé JJ.

Front Immunol. 2018 Jul 16;9:1609. doi: 10.3389/fimmu.2018.01609. eCollection 2018.

3.

Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering.

Zhu G, Falahat R, Wang K, Mailloux A, Artzi N, Mulé JJ.

Front Immunol. 2017 Jun 30;8:767. doi: 10.3389/fimmu.2017.00767. eCollection 2017.

4.

A Cell ELISA for the quantification of MUC1 mucin (CD227) expressed by cancer cells of epithelial and neuroectodermal origin.

Falahat R, Wiranowska M, Gallant ND, Toomey R, Hill R, Alcantar N.

Cell Immunol. 2015 Nov-Dec;298(1-2):96-103. doi: 10.1016/j.cellimm.2015.09.009. Epub 2015 Sep 28.

PMID:
26435344

Supplemental Content

Loading ...
Support Center